Status:
UNKNOWN
Deprescribing: a Portrait and Out-comes of the Reduction of Polypharmacy in Portugal
Lead Sponsor:
University of Beira Interior
Conditions:
Polypharmacy
Deprescriptions
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This study protocol comprises three phases. The first two phases will be nationwide and aim to evaluate the prevalence and patterns of polypharmacy and assess the barriers and facilitators of deprescr...
Detailed Description
Study design This is a three-phase study: 1. Cross-sectional, analytical study of the prevalence and patterns of polypharmacy, namely sociodemographic and clinical profiles (age, genre, area of resi...
Eligibility Criteria
Inclusion
- Patients attending to the primary care consultation in the selected health centres.
Exclusion
- Being acutely unwell in the last three weeks
- Refuse to participate
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2020
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT03283735
Start Date
September 1 2019
End Date
April 1 2020
Last Update
February 19 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.